The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Insomnia Pharmacological Treatment Market Research Report 2024
Synopsis
The global Insomnia Pharmacological Treatment market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 3710.3 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Insomnia Pharmacological Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insomnia Pharmacological Treatment.
Report Scope
The Insomnia Pharmacological Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insomnia Pharmacological Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insomnia Pharmacological Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eisai, Co. Ltd. (Japan)
Merck & Co., Inc (US)
Meda Consumer Healthcare Inc (US)
Pfizer, Inc (US)
Sanofi (France)
Takeda Pharmaceutical Company Ltd. (Japan)
Pernix Therapeutics (US)
Purdue Pharma L.P (US)
Segment by Type
Prescription Sleep Aids
Over-the-Counter Sleep Aids
Segment by Application
Homecare
Clinic
Hospital
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Insomnia Pharmacological Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Insomnia Pharmacological Treatment market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 3710.3 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Insomnia Pharmacological Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insomnia Pharmacological Treatment.
Report Scope
The Insomnia Pharmacological Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insomnia Pharmacological Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insomnia Pharmacological Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eisai, Co. Ltd. (Japan)
Merck & Co., Inc (US)
Meda Consumer Healthcare Inc (US)
Pfizer, Inc (US)
Sanofi (France)
Takeda Pharmaceutical Company Ltd. (Japan)
Pernix Therapeutics (US)
Purdue Pharma L.P (US)
Segment by Type
Prescription Sleep Aids
Over-the-Counter Sleep Aids
Segment by Application
Homecare
Clinic
Hospital
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Insomnia Pharmacological Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Pharmacological Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Prescription Sleep Aids
1.2.3 Over-the-Counter Sleep Aids
1.3 Market by Application
1.3.1 Global Insomnia Pharmacological Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Homecare
1.3.3 Clinic
1.3.4 Hospital
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Insomnia Pharmacological Treatment Market Perspective (2019-2030)
2.2 Insomnia Pharmacological Treatment Growth Trends by Region
2.2.1 Global Insomnia Pharmacological Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Insomnia Pharmacological Treatment Historic Market Size by Region (2019-2024)
2.2.3 Insomnia Pharmacological Treatment Forecasted Market Size by Region (2025-2030)
2.3 Insomnia Pharmacological Treatment Market Dynamics
2.3.1 Insomnia Pharmacological Treatment Industry Trends
2.3.2 Insomnia Pharmacological Treatment Market Drivers
2.3.3 Insomnia Pharmacological Treatment Market Challenges
2.3.4 Insomnia Pharmacological Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Insomnia Pharmacological Treatment Players by Revenue
3.1.1 Global Top Insomnia Pharmacological Treatment Players by Revenue (2019-2024)
3.1.2 Global Insomnia Pharmacological Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Insomnia Pharmacological Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Insomnia Pharmacological Treatment Revenue
3.4 Global Insomnia Pharmacological Treatment Market Concentration Ratio
3.4.1 Global Insomnia Pharmacological Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Pharmacological Treatment Revenue in 2023
3.5 Insomnia Pharmacological Treatment Key Players Head office and Area Served
3.6 Key Players Insomnia Pharmacological Treatment Product Solution and Service
3.7 Date of Enter into Insomnia Pharmacological Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Insomnia Pharmacological Treatment Breakdown Data by Type
4.1 Global Insomnia Pharmacological Treatment Historic Market Size by Type (2019-2024)
4.2 Global Insomnia Pharmacological Treatment Forecasted Market Size by Type (2025-2030)
5 Insomnia Pharmacological Treatment Breakdown Data by Application
5.1 Global Insomnia Pharmacological Treatment Historic Market Size by Application (2019-2024)
5.2 Global Insomnia Pharmacological Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Insomnia Pharmacological Treatment Market Size (2019-2030)
6.2 North America Insomnia Pharmacological Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Insomnia Pharmacological Treatment Market Size by Country (2019-2024)
6.4 North America Insomnia Pharmacological Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Insomnia Pharmacological Treatment Market Size (2019-2030)
7.2 Europe Insomnia Pharmacological Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Insomnia Pharmacological Treatment Market Size by Country (2019-2024)
7.4 Europe Insomnia Pharmacological Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Pharmacological Treatment Market Size (2019-2030)
8.2 Asia-Pacific Insomnia Pharmacological Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Insomnia Pharmacological Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Insomnia Pharmacological Treatment Market Size (2019-2030)
9.2 Latin America Insomnia Pharmacological Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Insomnia Pharmacological Treatment Market Size by Country (2019-2024)
9.4 Latin America Insomnia Pharmacological Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Pharmacological Treatment Market Size (2019-2030)
10.2 Middle East & Africa Insomnia Pharmacological Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eisai, Co. Ltd. (Japan)
11.1.1 Eisai, Co. Ltd. (Japan) Company Detail
11.1.2 Eisai, Co. Ltd. (Japan) Business Overview
11.1.3 Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Introduction
11.1.4 Eisai, Co. Ltd. (Japan) Revenue in Insomnia Pharmacological Treatment Business (2019-2024)
11.1.5 Eisai, Co. Ltd. (Japan) Recent Development
11.2 Merck & Co., Inc (US)
11.2.1 Merck & Co., Inc (US) Company Detail
11.2.2 Merck & Co., Inc (US) Business Overview
11.2.3 Merck & Co., Inc (US) Insomnia Pharmacological Treatment Introduction
11.2.4 Merck & Co., Inc (US) Revenue in Insomnia Pharmacological Treatment Business (2019-2024)
11.2.5 Merck & Co., Inc (US) Recent Development
11.3 Meda Consumer Healthcare Inc (US)
11.3.1 Meda Consumer Healthcare Inc (US) Company Detail
11.3.2 Meda Consumer Healthcare Inc (US) Business Overview
11.3.3 Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Introduction
11.3.4 Meda Consumer Healthcare Inc (US) Revenue in Insomnia Pharmacological Treatment Business (2019-2024)
11.3.5 Meda Consumer Healthcare Inc (US) Recent Development
11.4 Pfizer, Inc (US)
11.4.1 Pfizer, Inc (US) Company Detail
11.4.2 Pfizer, Inc (US) Business Overview
11.4.3 Pfizer, Inc (US) Insomnia Pharmacological Treatment Introduction
11.4.4 Pfizer, Inc (US) Revenue in Insomnia Pharmacological Treatment Business (2019-2024)
11.4.5 Pfizer, Inc (US) Recent Development
11.5 Sanofi (France)
11.5.1 Sanofi (France) Company Detail
11.5.2 Sanofi (France) Business Overview
11.5.3 Sanofi (France) Insomnia Pharmacological Treatment Introduction
11.5.4 Sanofi (France) Revenue in Insomnia Pharmacological Treatment Business (2019-2024)
11.5.5 Sanofi (France) Recent Development
11.6 Takeda Pharmaceutical Company Ltd. (Japan)
11.6.1 Takeda Pharmaceutical Company Ltd. (Japan) Company Detail
11.6.2 Takeda Pharmaceutical Company Ltd. (Japan) Business Overview
11.6.3 Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Introduction
11.6.4 Takeda Pharmaceutical Company Ltd. (Japan) Revenue in Insomnia Pharmacological Treatment Business (2019-2024)
11.6.5 Takeda Pharmaceutical Company Ltd. (Japan) Recent Development
11.7 Pernix Therapeutics (US)
11.7.1 Pernix Therapeutics (US) Company Detail
11.7.2 Pernix Therapeutics (US) Business Overview
11.7.3 Pernix Therapeutics (US) Insomnia Pharmacological Treatment Introduction
11.7.4 Pernix Therapeutics (US) Revenue in Insomnia Pharmacological Treatment Business (2019-2024)
11.7.5 Pernix Therapeutics (US) Recent Development
11.8 Purdue Pharma L.P (US)
11.8.1 Purdue Pharma L.P (US) Company Detail
11.8.2 Purdue Pharma L.P (US) Business Overview
11.8.3 Purdue Pharma L.P (US) Insomnia Pharmacological Treatment Introduction
11.8.4 Purdue Pharma L.P (US) Revenue in Insomnia Pharmacological Treatment Business (2019-2024)
11.8.5 Purdue Pharma L.P (US) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
